Multiome Analysis of Cerebellar Development and its Dysregulation in Medulloblastoma 2026 Momentum Fellow Emily Ringwalt, PhD, Nationwide Children's Hospital Read More
Tissue-Infiltrating Clonal Hematopoiesis Dynamics: Investigating a Hidden Enemy Promoting Tumor Initiation 2026 Momentum Fellow Constandina Pospori, MB, PhD, Francis Crick Institute Read More
Investigating the Role of Lipid Alterations in Promoting Immunosuppression in Brain Tumor Macrophages 2026 Momentum Fellow Bastien Dolfi, PhD, University of Lausanne, Switzerland Read More
Assessing HIV-Specific T Cells Against Non-Escape Epitope Targets (HST-NEETs) in Combination with a Stress Ligand Chimeric Antigen Receptor (CAR) as a Novel Therapeutic for HIV-Associated Lymphomas 2026 Momentum Fellow Brita Ostermeier, PhD, Children's National Hospital Read More
Aneuploidies as a Source of Therapeutic Targets in Glioblastoma Endeavor Award in Partnership with The Sontag Foundation, The Anne and Claude Berda Foundation, the National Brain Tumor Society, the Southeastern Brain Tumor Foundation, and the Uncle Kory Foundation Rameen Beroukhim, MD, PhD; William Kaelin Jr., MD; and Keith Ligon, MD, PhD, Broad Institute of MIT and Harvard and Dana-Farber Cancer Institute; Daniel Schramek, PhD, Lunenfeld-Tanenbaum Research Institute; Jason Moffat, PhD, The Hospital for Sick Children Read More
Antisense Oligonucleotides (ASOs) Targeting the Long Noncoding RNA as Novel Immunotherapeutic Agents in Glioblastoma ASPIRE Award in Partnership with The Sontag Foundation, The Anne and Claude Berda Foundation, the National Brain Tumor Society, the Southeastern Brain Tumor Foundation, and the Uncle Kory Foundation E. Antonio Chiocca, MD, PhD, and Marco Mineo, PhD, Brigham and Women's Hospital Read More
Targeting Platelet-Immune Cell Interactions for Next-Generation Glioblastoma Therapies ASPIRE Award in Partnership with The Sontag Foundation, The Anne and Claude Berda Foundation, the National Brain Tumor Society, the Southeastern Brain Tumor Foundation, and the Uncle Kory Foundation Justin Lathia, PhD, Cleveland Clinic Lerner Research Institute Read More
Detection and Interception of KRAS-Mutant Pancreatic Cancer Using Small Molecule RAS(ON) Inhibitors 2026 Mark Foundation-AACR-Lustgarten Foundation Early Detection Award Brian M. Wolpin, MD, MPH, and Andrew J. Aguirre, MD, PhD, Dana-Farber Cancer Institute; Julie L. Sutcliffe, PhD, University of California, Davis; Laura D. Wood, MD, PhD, Johns Hopkins University Read More
Programmable Recognition of KRAS Neoantigens for Early Cancer Diagnostics Across Patients 2026 Mark Foundation-AACR-Lustgarten Foundation Early Detection Award Nikolaos G. Sgourakis, PhD, Children’s Hospital of Philadelphia and University of Pennsylvania; Mark A. Sellmyer, MD, PhD, University of Pennsylvania; Possu Huang, PhD, Stanford University Read More
